Skip to content

A Study to Find Out How Common the Fungal Infection Aspergillosis is in the Patients Who Have Suffered from Pulmonary Tuberculosis in the Past

Unmasking Chronic Pulmonary Aspergillosis: A Prevalence Study in Post Tuberculosis Patients in Outpatients at a Tertiary Care Centre - CPA

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/07/113216
Enrollment
140
Registered
2026-07-01
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B449- Aspergillosis, unspecified Health Condition 2: B908- Sequelae of tuberculosis of otherorgans Health Condition 3: A150- Tuberculosis of lung

Interventions

Intervention1: Nil: Nil

Sponsors

Dr Shipra Anand
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Treated cases of pulmonary tuberculosis and declared cured successfully as per the NTEP guideline with recurrent symptoms or worsening of symptoms of post TB patients including cough, fever, haemoptysis, breathlessness, chest pain, with or without radiological worsening for 3 months. The patients are not responding to regular therapy for post-TB obstructive lung disease and any other alternative diagnosis has been ruled out.

Exclusion criteria

Exclusion criteria: Active pulmonary tuberculosis including patients on multi drug resistant TB treatment. Pregnant or lactating women. Patients with MDR or XDR TB treatment.

Design outcomes

Primary

MeasureTime frame
Prevalence of chronic pulmonary aspergillosis, clinical features of CPA, and potential risk factors associated with the development of CPA in post tubercular patients.Timepoint: 1 year after the study begins which is at the end of the study duration

Secondary

MeasureTime frame
Diagnostic challenges of CPA among patients who have completed treatment for pulmonary tuberculosisTimepoint: 1 year after the study begins which is at the end of the study duration

Countries

India

Contacts

Public ContactDr Shipra Anand

Lok Nayak Hospital, Maulana Azad Medical College

shiprapulmonary@gmail.com7838703907

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026